Analytical comparability study of recombinant monoclonal antibody therapeutics
Аналитическое исследование сопоставимости рекомбинантных терапевтических моноклональных антител
2018-03-07
SCID: 54.1/p4q4vfdf
Discuss with AI
analytical comparabilitycomparability studiesprocess changesproduct quality attributesrecombinant monoclonal antibodies
Figures from the paper
Abstract (AI)
Process changes are inevitable in the life cycle of recombinant monoclonal antibody therapeutics. Products made using pre- and post-change processes are required to be comparable as demonstrated by comparability studies to qualify for continuous development and commercial supply. Establishment of comparability is a systematic process of gathering and evaluating data based on scientific understanding and clinical experience of the relationship between product quality attributes and their impact on safety and efficacy. This review summarizes the current understanding of various modifications of recombinant monoclonal antibodies. It further outlines the critical steps in designing and executing successful comparability studies to support process changes at different stages of a product's lifecycle.
Key Findings
1
Comparability is established by systematically evaluating data linking product quality attributes with potential impacts on safety and efficacy.
2
Pre- and post-change products must demonstrate comparability to support continued development and commercial supply.
3
Process changes are inevitable throughout the lifecycle of recombinant monoclonal antibody therapeutics.
4
The review summarizes current knowledge of recombinant monoclonal antibody modifications and outlines critical steps for designing and executing comparability studies across product lifecycle stages.
Research Object
recombinant monoclonal antibody therapeutics manufactured using pre- and post-change processes
Research Subject
analytical comparability of product quality attributes and their implications for safety and efficacy across process changes
Publication Details
Publication Date
2018-03-07
Journal
Publisher
ISSN
Cited by
102
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest